메뉴 건너뛰기




Volumn 280, Issue 1, 1998, Pages 93-95

The case for conservative management of early HIV disease

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS MUTATION;

EID: 0032122370     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.1.93     Document Type: Note
Times cited : (27)

References (26)
  • 1
    • 0030979361 scopus 로고    scopus 로고
    • Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society-USA panel
    • Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA. 1997;277:1962-1969.
    • (1997) JAMA , vol.277 , pp. 1962-1969
    • Carpenter, C.C.J.1    Fischl, M.A.2    Hammer, S.M.3
  • 3
    • 16944367032 scopus 로고    scopus 로고
    • HIV infection induces changes in CD4 T-cell phenotype and within the CD4 T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
    • Conners M, Kovacs JA, Krevet S, et al. HIV infection induces changes in CD4 T-cell phenotype and within the CD4 T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997;3:533-540.
    • (1997) Nat Med. , vol.3 , pp. 533-540
    • Conners, M.1    Kovacs, J.A.2    Krevet, S.3
  • 4
    • 3543008381 scopus 로고    scopus 로고
    • Immunological reconstitution after triple combination therapy in HIV-1 infection: A composition of redistribution and proliferation
    • February 1-5, Chicago, Ill. Abstract 20
    • Miedema F, Pakker NG, Notermans DW, et al. Immunological reconstitution after triple combination therapy in HIV-1 infection: a composition of redistribution and proliferation. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1-5, 1998; Chicago, Ill. Abstract 20.
    • (1998) Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections
    • Miedema, F.1    Pakker, N.G.2    Notermans, D.W.3
  • 6
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
    • Palella F Jr, Delany K, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
    • (1998) N Engl J Med. , vol.338 , pp. 853-860
    • Palella Jr., F.1    Delany, K.2    Moorman, A.3
  • 7
    • 17344373825 scopus 로고    scopus 로고
    • Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
    • Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis. 1998;177:1080-1083.
    • (1998) J Infect Dis. , vol.177 , pp. 1080-1083
    • Tural, C.1    Romeu, J.2    Sirera, G.3
  • 8
    • 0001633495 scopus 로고    scopus 로고
    • Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
    • Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 1996;273:1856-1862.
    • (1996) Science , vol.273 , pp. 1856-1862
    • Dean, M.1    Carrington, M.2    Winkler, C.3
  • 9
    • 0442268112 scopus 로고    scopus 로고
    • A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    • Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
    • (1997) N Engl J Med. , vol.337 , pp. 725-733
    • Hammer, S.M.1    Squires, K.E.2    Hughes, M.D.3
  • 10
    • 0027510616 scopus 로고
    • Hepatomegaly with severe steatosis in HIV-seropositive patients
    • Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS. 1993;7:379-385.
    • (1993) AIDS , vol.7 , pp. 379-385
    • Freiman, J.P.1    Helfert, K.E.2    Hamrell, M.R.3    Stein, D.S.4
  • 12
    • 17144463863 scopus 로고    scopus 로고
    • Severe premature coronary artery disease with protease inhibitors
    • Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328.
    • (1998) Lancet , vol.351 , pp. 1328
    • Henry, K.1    Melroe, H.2    Huebsch, J.3
  • 13
    • 0029132121 scopus 로고
    • Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
    • Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
    • (1995) Circulation , vol.92 , pp. 1326-1331
    • Furberg, C.D.1    Psaty, B.M.2    Meyer, J.V.3
  • 14
    • 0013586127 scopus 로고    scopus 로고
    • Bi-directional inhibition of HIV-1 drug resistance selection by combination therapy with indinavir and reverse transcriptase inhibitors
    • July 7-12, Vancouver, British Columbia. Abstract Th.B.932
    • Condra JH, Holder DJ, Schleif WA. Bi-directional inhibition of HIV-1 drug resistance selection by combination therapy with indinavir and reverse transcriptase inhibitors. In: Program and abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia. Abstract Th.B.932.
    • (1996) Program and Abstracts of the XI International Conference on AIDS
    • Condra, J.H.1    Holder, D.J.2    Schleif, W.A.3
  • 15
    • 0024244030 scopus 로고
    • Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily
    • Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther. 1988;44:540-545.
    • (1988) Clin Pharmacol Ther. , vol.44 , pp. 540-545
    • Pullar, T.1    Birtwell, A.J.2    Wiles, P.G.3    Hay, A.4    Feely, M.P.5
  • 16
    • 0024343414 scopus 로고
    • How often is medication taken as prescribed? A novel assessment technique
    • Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oullette VL. How often is medication taken as prescribed? a novel assessment technique. JAMA. 1989; 261:3273-3277.
    • (1989) JAMA , vol.261 , pp. 3273-3277
    • Cramer, J.A.1    Mattson, R.H.2    Prevey, M.L.3    Scheyer, R.D.4    Oullette, V.L.5
  • 17
    • 0023088805 scopus 로고
    • Tuberculosis in physicians: Compliance with preventive measures
    • Geiseler PJ, Nelson KE, Crispen RG. Tuberculosis in physicians: compliance with preventive measures. Am Rev Respir Dis. 1987;135:3-9.
    • (1987) Am Rev Respir Dis. , vol.135 , pp. 3-9
    • Geiseler, P.J.1    Nelson, K.E.2    Crispen, R.G.3
  • 18
    • 0018166371 scopus 로고
    • Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen
    • Roth H, Caron H. Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen. Clin Pharmacol Ther. 1978;23:361-370.
    • (1978) Clin Pharmacol Ther. , vol.23 , pp. 361-370
    • Roth, H.1    Caron, H.2
  • 19
    • 0007236958 scopus 로고    scopus 로고
    • Indinavir compliance in a large urban HIV clinic
    • Lennox JL, Harnett G, Patel K. Indinavir compliance in a large urban HIV clinic. Clin Infect Dis. 1997;25:397.
    • (1997) Clin Infect Dis. , vol.25 , pp. 397
    • Lennox, J.L.1    Harnett, G.2    Patel, K.3
  • 20
    • 3543030486 scopus 로고    scopus 로고
    • Recent experience with post-exposure prophylaxis (PEP) with combination antiretrovirals for occupational exposure (OE) to HIV
    • Steger KA, Swotinsky R, Snyder S, Craven DE. Recent experience with post-exposure prophylaxis (PEP) with combination antiretrovirals for occupational exposure (OE) to HIV. Clin Infect Dis. 1997-25:444.
    • (1997) Clin Infect Dis. , vol.25 , pp. 444
    • Steger, K.A.1    Swotinsky, R.2    Snyder, S.3    Craven, D.E.4
  • 21
    • 0008646434 scopus 로고    scopus 로고
    • Human immunodeficiency virus postexposure prophylaxis following occupational HIV exposure: Findings from the HIV PEP Registry
    • Wang SA, and the HIV PEP Registry Group. Human immunodeficiency virus postexposure prophylaxis following occupational HIV exposure: findings from the HIV PEP Registry. Clin Infect Dis. 1998;25:444.
    • (1998) Clin Infect Dis. , vol.25 , pp. 444
    • Wang, S.A.1
  • 22
    • 0028943992 scopus 로고
    • In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
    • Condra JH, Schleif WA, Blahy OM, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 1995;374:569-571.
    • (1995) Nature , vol.374 , pp. 569-571
    • Condra, J.H.1    Schleif, W.A.2    Blahy, O.M.3
  • 24
    • 0031587216 scopus 로고    scopus 로고
    • Gonorrhea among men who have sex with men - Selected sexually transmitted disease clinics, 1993-1996
    • Centers for Disease Control and Prevention. Gonorrhea among men who have sex with men - selected sexually transmitted disease clinics, 1993-1996. MMWR Morb Mortal Wkly Rep. 1997;46:889-892.
    • (1997) MMWR Morb Mortal Wkly Rep. , vol.46 , pp. 889-892
  • 25
    • 0031021203 scopus 로고    scopus 로고
    • Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project
    • Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis. 1997;24(suppl):S121-S130.
    • (1997) Clin Infect Dis. , vol.24 , Issue.SUPPL.
    • Cohn, D.L.1    Bustreo, F.2    Raviglione, M.C.3
  • 26
    • 0030935802 scopus 로고    scopus 로고
    • British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
    • BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet. 1997;349:1086-1092.
    • (1997) Lancet , vol.349 , pp. 1086-1092


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.